Bicycle Therapeutics Plc (BCYC)
3.54
+0.08
(+2.31%)
USD |
NASDAQ |
Oct 19, 16:00
3.54
0.00 (0.00%)
After-Hours: 16:14
Bicycle Therapeutics Cash from Operations (Annual) : -250.26M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -250.26M |
| December 31, 2024 | -164.79M |
| December 31, 2023 | -60.86M |
| December 31, 2022 | -86.06M |
| December 31, 2021 | -14.79M |
| Date | Value |
|---|---|
| December 31, 2020 | -17.93M |
| December 31, 2019 | -28.73M |
| December 31, 2018 | -26.03M |
| December 31, 2017 | -1.430M |
| December 31, 2016 | -11.27M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Autolus Therapeutics Plc | -284.23M |
| Cellectis SA | -40.14M |
| Akari Therapeutics Plc | -10.59M |
| DBV Technologies SA | -121.56M |
| Biodexa Pharmaceuticals Plc | -7.268M |